Neuropathic pain: mechanisms, sex differences, and potential therapies for a global problem

S Ghazisaeidi, MM Muley… - Annual review of …, 2023 - annualreviews.org
The study of chronic pain continues to generate ever-increasing numbers of publications,
but safe and efficacious treatments for chronic pain remain elusive. Recognition of sex …

[HTML][HTML] Progress in the treatment of diabetic peripheral neuropathy

K Yang, Y Wang, Y Li, Y Chen, N **ng, H Lin… - Biomedicine & …, 2022 - Elsevier
Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of
diabetes. Symptoms of DPN mainly include spontaneous intractable pain that is diffuse and …

Challenges of neuropathic pain: focus on diabetic neuropathy

DC Rosenberger, V Blechschmidt… - Journal of Neural …, 2020 - Springer
Neuropathic pain is a frequent condition caused by a lesion or disease of the central or
peripheral somatosensory nervous system. A frequent cause of peripheral neuropathic pain …

[HTML][HTML] Cellular and molecular mechanisms of pain

AI Basbaum, DM Bautista, G Scherrer, D Julius - Cell, 2009 - cell.com
The nervous system detects and interprets a wide range of thermal and mechanical stimuli,
as well as environmental and endogenous chemical irritants. When intense, these stimuli …

Status of peripheral sodium channel blockers for non-addictive pain treatment

M Alsaloum, GP Higerd, PR Effraim… - Nature Reviews …, 2020 - nature.com
The effective and safe treatment of pain is an unmet health-care need. Current medications
used for pain management are often only partially effective, carry dose-limiting adverse …

Conus venom peptide pharmacology

RJ Lewis, S Dutertre, I Vetter, MDJ Christie - Pharmacological reviews, 2012 - Elsevier
Conopeptides are a diverse group of recently evolved venom peptides used for prey capture
and/or defense. Each species of cone snails produces in excess of 1000 conopeptides, with …

Prostaglandin E2 and pain—an update

A Kawabata - Biological and Pharmaceutical Bulletin, 2011 - jstage.jst.go.jp
Prostaglandin E2 (PGE2), a cyclooxygenase (COX) product, is the best known lipid mediator
that contributes to inflammatory pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) …

Peripheral voltage-gated cation channels in neuropathic pain and their potential as therapeutic targets

SRA Alles, PA Smith - Frontiers in Pain Research, 2021 - frontiersin.org
The persistence of increased excitability and spontaneous activity in injured peripheral
neurons is imperative for the development and persistence of many forms of neuropathic …

Neuropathic pain; what we know and what we should do about it

PA Smith - Frontiers in Pain Research, 2023 - frontiersin.org
Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously
difficult to treat. Peripheral nerve injury promotes Schwann cell activation and invasion of …

Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs

AE Olesen, T Andresen, C Staahl, AM Drewes - Pharmacological reviews, 2012 - Elsevier
Pain models in animals have shown low predictivity for analgesic efficacy in humans, and
clinical studies are often very confounded, blurring the evaluation. Human experimental pain …